Background and Aims: Vitamin D deficiency has been associated with disease activity in Crohn’s disease (CD). We assessed whether there is a correlation between vitamin D levels and the risk of postoperative recurrence in CD. Methods: CD patients who underwent surgery were identified from a prospectively maintained database at the University of Chicago. The primary endpoint was the correlation of serum 25-hydroxy vitamin D levels measured at 6–12 months after surgery and the proportion of patients in endoscopic remission, defined as a simple endoscopic score for CD of 0. Clinical, biological (C-reactive protein), and histologic recurrences were also studied. Results: Among a total of 89 patients, 17, 46, and 26 patients had vitamin D levels of <15, 15–30, and >30 ng/mL, respectively. Patients with higher vitamin D levels were significantly more likely to be in endoscopic remission compared to those with lower levels (23, 42, and 67% in ascending tertile order; p = 0.028). On multivariate analysis, vitamin D >30 ng/mL (odds ratio [OR] 0.22, 95% confidence interval [CI] 0.07–0.66, p = 0.006) and anti-tumor necrosis factor agent treatment (OR 0.25, 95% CI 0.08–0.83, p = 0.01) were associated with reduced risk of endoscopic recurrence. Rates of clinical, biological, and histologic remission trended to be higher in patients with higher vitamin D levels (p = 0.17, 0.55, 0.062, respectively). Conclusion: In the present study, higher vitamin D level was associated with lower risk of postoperative endoscopic CD recurrence. Further, studies are warranted to assess the role of vitamin D in postoperative CD recurrence.

1.
Sakuraba
A
,
Sato
T
,
Kamada
N
,
Kitazume
M
,
Sugita
A
,
Hibi
T
.
Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn’s disease
.
Gastroenterology
.
2009
;
137
(
5
):
1736
45
.http://dx.doi.org/10.1053/j.gastro.2009.07.049.
2.
Sato
T
,
Kanai
T
,
Watanabe
M
,
Sakuraba
A
,
Okamoto
S
,
Nakai
T
,
.
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease
.
Gastroenterology
.
2004
;
126
(
3
):
829
39
.http://dx.doi.org/10.1053/j.gastro.2003.12.011.
3.
Rutgeerts
P
,
Diamond
RH
,
Bala
M
,
Olson
A
,
Lichtenstein
GR
,
Bao
W
,
.
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease
.
Gastrointest Endosc
.
2006
;
63
(
3
):
433
64
; quiz 464
.http://dx.doi.org/10.1016/j.gie.2005.08.011.
4.
Geboes
K
,
Rutgeerts
P
,
Opdenakker
G
,
Olson
A
,
Patel
K
,
Wagner
CL
,
.
Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn’s disease
.
Curr Med Res Opin
.
2005
;
21
(
11
):
1741
54
.http://dx.doi.org/10.1185/030079905X65457.
5.
Rutgeerts
P
,
Geboes
K
,
Vantrappen
G
,
Beyls
J
,
Kerremans
R
,
Hiele
M
.
Predictability of the postoperative course of Crohn’s disease
.
Gastroenterology
.
1990
;
99
(
4
):
956
63
.http://dx.doi.org/10.1016/0016-5085(90)90613-6.
6.
Reinisch
W
,
Angelberger
S
,
Petritsch
W
,
Shonove
O
,
Lukas
M
,
Bar-Meir
S
,
.
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn’s disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial
.
Gut
.
2010
;
59
(
6
):
752
9
.
7.
Hanauer
SB
,
Korelitz
BI
,
Rutgeerts
P
,
Peppercorn
MA
,
Thisted
RA
,
Cohen
RD
,
.
Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial
.
Gastroenterology
.
2004
;
127
(
3
):
723
9
.
8.
Rutgeerts
P
,
Hiele
M
,
Geboes
K
,
Peeters
M
,
Penninckx
F
,
Aerts
R
,
.
Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection
.
Gastroenterology
.
1995
;
108
(
6
):
1617
21
.http://dx.doi.org/10.1016/0016-5085(95)90121-3.
9.
Regueiro
M
,
Schraut
W
,
Baidoo
L
,
Kip
KE
,
Sepulveda
AR
,
Pesci
M
,
.
Infliximab prevents Crohn’s disease recurrence after ileal resection
.
Gastroenterology
.
2009
;
136
(
2
):
441
716;
quiz 71.http://dx.doi.org/10.1053/j.gastro.2008.10.051
10.
Sakuraba
A
,
Sato
T
,
Matsukawa
H
,
Okamoto
S
,
Takaichi
H
,
Ogata
H
,
.
The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn’s disease patients: a pilot open-labeled prospective study
.
Int J Colorectal Dis
.
2012
;
27
(
7
):
947
52
.
11.
Ardesia
M
,
Ferlazzo
G
,
Fries
W
.
Vitamin D and inflammatory bowel disease
.
Biomed Res Int
.
2015
;
2015
:
470805
.http://dx.doi.org/10.1155/2015/470805.
12.
Reich
KM
,
Fedorak
RN
,
Madsen
K
,
Kroeker
KI
.
Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review
.
World J Gastroenterol
.
2014
;
20
(
17
):
4934
47
.http://dx.doi.org/10.3748/wjg.v20.i17.4934.
13.
Froicu
M
,
Weaver
V
,
Wynn
TA
,
McDowell
MA
,
Welsh
JE
,
Cantorna
MT
.
A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases
.
Mol Endocrinol
.
2003
;
17
(
12
):
2386
92
.http://dx.doi.org/10.1210/me.2003-0281.
14.
Cantorna
MT
,
Munsick
C
,
Bemiss
C
,
Mahon
BD
.
1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease
.
J Nutr
.
2000
;
130
(
11
):
2648
52
.http://dx.doi.org/10.1093/jn/130.11.2648.
15.
Wang
TT
,
Dabbas
B
,
Laperriere
D
,
Bitton
AJ
,
Soualhine
H
,
Tavera-Mendoza
LE
,
.
Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease
.
J Biol Chem
.
2010
;
285
(
4
):
2227
31
.http://dx.doi.org/10.1074/jbc.C109.071225.
16.
Sun
J
.
VDR/vitamin D receptor regulates autophagic activity through ATG16L1
.
Autophagy
.
2016
;
12
(
6
):
1057
8
.http://dx.doi.org/10.1080/15548627.2015.1072670.
17.
Vandamme
D
,
Landuyt
B
,
Luyten
W
,
Schoofs
L
.
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
.
Cell Immunol
.
2012
;
280
(
1
):
22
35
.http://dx.doi.org/10.1016/j.cellimm.2012.11.009.
18.
Basson
A
.
Vitamin D and Crohn’s disease in the adult patient: a review
.
JPEN J Parenter Enteral Nutr
.
2014
;
38
(
4
):
438
58
.
19.
Jorgensen
SP
,
Agnholt
J
,
Glerup
H
,
Lyhne
S
,
Villadsen
GE
,
Hvas
CL
,
.
Clinical trial: vitamin D3 treatment in Crohn’s disease: a randomized double-blind placebo-controlled study
.
Aliment Pharmacol Ther
.
2010
;
32
(
3
):
377
83
.
20.
Lorinczy
K
,
Lakatos
PL
,
Toth
M
,
Salamon
A
,
Nemes
A
,
Csontos
AA
,
.
Vitamin D level in Hungarian patients with inflammatory bowel diseases
.
Orv Hetil
.
2013
;
154
(
46
):
1821
8
.
21.
Daperno
M
,
D’Haens
G
,
Van Assche
G
,
Baert
F
,
Bulois
P
,
Maunoury
V
,
.
Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD
.
Gastrointest Endosc
.
2004
;
60
(
4
):
505
12
.
22.
Yamada
A
,
Komaki
Y
,
Patel
N
,
Komaki
F
,
Pekow
J
,
Dalal
S
,
.
The use of vedolizumab in preventing postoperative recurrence of Crohn’s disease
.
Inflamm Bowel Dis
.
2018
;
24
(
3
):
502
9
.http://dx.doi.org/10.1093/ibd/izx054.
23.
Anyane-Yeboa
A
,
Yamada
A
,
Haider
H
,
Wang
Y
,
Komaki
Y
,
Komaki
F
,
.
A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn’s disease
.
Aliment Pharmacol Ther
.
2018
;
48
(
9
):
933
40
.http://dx.doi.org/10.1111/apt.14951.
24.
Rubin
DT
,
Huo
D
,
Kinnucan
JA
,
Sedrak
MS
,
McCullom
NE
,
Bunnag
AP
,
.
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study
.
Clin Gastroenterol Hepatol
.
2013
;
11
(
12
):
1601
8.e–14
.http://dx.doi.org/10.1016/j.cgh.2013.06.023.
25.
Kanda
Y
.
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
.
Bone Marrow Transplant
.
2013
;
48
(
3
):
452
8
.http://dx.doi.org/10.1038/bmt.2012.244.
26.
Sun
J
.
Vitamin D and mucosal immune function
.
Curr Opin Gastroenterol
.
2010
;
26
(
6
):
591
5
.http://dx.doi.org/10.1097/MOG.0b013e32833d4b9f.
27.
Pappa
HM
,
Langereis
EJ
,
Grand
RJ
,
Gordon
CM
.
Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease
.
J Pediatr Gastroenterol Nutr
.
2011
;
53
(
4
):
361
4
.http://dx.doi.org/10.1097/MPG.0b013e3182250b3e.
28.
Ulitsky
A
,
Ananthakrishnan
AN
,
Naik
A
,
Skaros
S
,
Zadvornova
Y
,
Binion
DG
,
.
Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life
.
JPEN J Parenter Enteral Nutr
.
2011
;
35
(
3
):
308
16
.http://dx.doi.org/10.1177/0148607110381267.
29.
Ananthakrishnan
AN
,
Cagan
A
,
Gainer
VS
,
Cai
T
,
Cheng
SC
,
Savova
G
,
.
Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease
.
Inflamm Bowel Dis
.
2013
;
19
(
9
):
1921
7
.http://dx.doi.org/10.1097/MIB.0b013e3182902ad9.
30.
Vester-Andersen
MK
,
Prosberg
MV
,
Jess
T
,
Andersson
M
,
Bengtsson
BG
,
Blixt
T
,
.
Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy
.
Am J Gastroenterol
.
2014
;
109
(
5
):
705
14
.http://dx.doi.org/10.1038/ajg.2014.45.
31.
Frolkis
AD
,
Dykeman
J
,
Negrón
ME
,
Debruyn
J
,
Jette
N
,
Fiest
KM
,
.
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies
.
Gastroenterology
.
2013
;
145
(
5
):
996
1006
.http://dx.doi.org/10.1053/j.gastro.2013.07.041.
32.
De Cruz
P
,
Kamm
MA
,
Hamilton
AL
,
Ritchie
KJ
,
Krejany
EO
,
Gorelik
A
,
.
Crohn’s disease management after intestinal resection: a randomised trial
.
Lancet
.
2015
;
385
(
9976
):
1406
17
.
33.
Narula
N
,
Cooray
M
,
Anglin
R
,
Muqtadir
Z
,
Narula
A
,
Marshall
JK
.
Impact of high-dose vitamin D3 supplementation in patients with Crohn’s disease in remission: a pilot randomized double-blind controlled study
.
Dig Dis Sci
.
2017
;
62
(
2
):
448
55
.
34.
de Bruyn
JR
,
Bossuyt
P
,
Ferrante
M
,
West
RL
,
Dijkstra
G
,
Witteman
BJ
,
.
High-dose vitamin D does not prevent postoperative recurrence of Crohn’s disease in a randomized placebo-controlled trial
.
Clin Gastroenterol Hepatol
.
2020 May 24
;
S1542–3565
(
20
):
30698
4
..
35.
Suibhne
TN
,
Cox
G
,
Healy
M
,
O’Morain
C
,
O’Sullivan
M
.
Vitamin D deficiency in Crohn’s disease: prevalence, risk factors and supplement use in an outpatient setting
.
J Crohns Colitis
.
2012
;
6
(
2
):
182
8
.
36.
Zhang
H
,
Ahn
J
,
Yu
K
.
Comparing statistical methods for removing seasonal variation from vitamin D measurements in case-control studies
.
Stat Interface
.
2011
;
4
(
1
):
85
93
.http://dx.doi.org/10.4310/SII.2011.v4.n1.a9.
You do not currently have access to this content.